Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversal

Telomir Pharmaceuticals Announces Closing of Initial Public Offering

Telomir Pharmaceuticals Announces Pricing of Initial Public Offering